JP Stock MarketDetailed Quotes
4875 MediciNova
- 220
- 00.00%
20min DelayMarket Closed May 17 15:00 JST
10.79BMarket Cap-9176P/E (Static)
225High217Low26.90KVolume219Open220Pre Close5.94MTurnover39252wk High0.06%Turnover Ratio49.05MShares17252wk Low-25.734EPS TTM9.26BFloat Cap1496Historical HighLossP/E (Static)42.09MShs Float129Historical Low-23.974EPS LYR3.64%Amplitude--Dividend TTM1.17P/B100Lot Size--Div YieldTTM
About MediciNova Company
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
Company Profile
Symbol4875
Company NameMediciNova
Founded2000-09-26
Fiscal Year Ends12-31
Address4275 Executive Square Suite 300
Zip Code105-0003
Phone03-3519-5010
Company Executives
- Name
- Position
- Salary
- Dr. Yuichi Iwaki,M.D.,PhD
- Chairman of the Board, President and Chief Executive Officer
- 1.39M
- David H. Crean, PhD
- Chief Business Officer
- --
- Jason J. Kruger
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Kazuko Matsuda
- Director and Chief Medical Officer
- 1.01M
- Hideki Nagao
- Independent Director
- 69.23K
- Carolyn D. Beaver, C.P.A.
- Independent Director
- 69.23K
- Nicole Lemerond
- Independent Director
- 46.16K
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
%Chg